Gilead Sciences | Resultado Líquido



Net Income Alterar Data
AbbVie USD 938M 348M 2025-06
Agios Pharmaceuticals USD -112020000 22.73M 2025-06
ALKERMES USD 87.1M 64.63M 2025-06
Alnylam Pharmaceuticals USD -66277000 8.8M 2025-06
Amgen USD 1.43B 298M 2025-06
Biogen USD 634.8M 394.3M 2025-06
BioMarin Pharmaceutical USD 240.53M 54.85M 2025-06
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
Eli Lilly USD 5.66B 2.9B 2025-06
Gilead Sciences USD 1.96B 645M 2025-06
GlaxoSmithKline GBP 1.44B 181M 2025-06
Glaxosmithkline GBP 414M 472M 2024-12
Incyte USD 405M 246.8M 2025-06
J&J USD 5.54B 5.46B 2025-06
Merck USD 4.43B 652M 2025-06
Moderna USD -825000000 146M 2025-06
Neurocrine Biosciences USD 107.5M 99.6M 2025-06
Novartis USD 4.02B 418M 2025-06
Pfizer USD 2.91B 58M 2025-06
PTC Therapeutics USD -64849000 931.41M 2025-06
Regeneron Pharmaceuticals USD 1.39B 582.9M 2025-06
Sanofi EUR 3.94B 2.07B 2025-06
Sarepta Therapeutics USD 196.89M 644.4M 2025-06
United Therapeutics USD 309.5M 12.7M 2025-06
Vertex Pharmaceuticals USD 1.03B 386.6M 2025-06


Gilead Sciences Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.